Dynamic left ventricular outflow tract obstruction without basal septal hypertrophy, caused by catecholamine therapy and volume depletion by Yang, Ji Hyun et al.
The  Korean  Journal  of  Internal  Medicine  :  23:106-109,  2008
Dynamic left ventricular outflow tract obstruction without basal 
septal hypertrophy, caused by catecholamine therapy and 
volume depletion 
Ji  Hyun  Yang,  M.D.,  Seung  Woo  Park,  M.D.,  Jeong  Hoon  Yang,  M.D., 
Sung  Won  Cho,  M.D.,  Hyo  Song  Kim,  M.D.,
  Kyoung  A  Choi,  M.D.  and  Ho  Joong  Kim,  M.D.
Departments  of  Internal  Medicine,  Samsung  Medical  Center, 
Sungkyunkwan  University  School  of  Medicine,  Seoul,  Korea
Hypertrophic  cardiomyopathy  (HCM)  with  hypertrophy  of  the  basal s e p t u m  i s  t h e  m o s t  c o m m o n  e t i o l o g y  o f  l e f t  
ventricular  outflow  tract  (LVOT)  obstruction. 
In  this  article,  we  report  the  case  of  a  patient  with  a  structurally  normal  heart  who  developed  hemodynamic 
deterioration due to severe LVOT obstruction following treatment with catecholamines. Hypovolemia accompanied with 
a  hyperdynamic  condition,  resulting  from  catecholamine  treatment,  may  cause  dynamic  LVOT  obstruction  due  to  the 
systolic anterior motion of the mitral valve leaflet. The solution for this is early recognition and correction of aggravating 
factors  such  as,  withdrawal  of  catecholamine  therapy  and  volume  replacement.
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INTRODUCTION
Hypertrophic  cardiomyopathy  (HCM)  is  the  most  common 
cause  of  dynamic  left  ventricular  outflow  tract  (LVOT)  obstruc-
tion.  The  hypertrophy  of  the  basal  septum  and  systolic  anterior 
motion  of  the  mitral  valve  leaflet  (SAM)  cause  a  dynamic 
obstruction in the LVOT
1-3). The dynamic LVOT obstruction may 
occur  as  a  result  of  other  conditions  such  as,  aortic  valve 
replacement  for  aortic  stenosis,  hypertensive  hypertrophy, 
dehydration,  sepsis,  vasodilatation,  acute  myocardial  infarction, 
and  mitral  valve  repair;  however,  it  has  also  been  observed  in 
patients  with  structurally  normal  hearts  who  have  been  treated 
with  catecholamine
4, 5).
In this article, we report the case of a patient who developed 
SAM,  and  severe  dynamic  LVOT  obstruction,  compromised  by 
haemodynamic  deterioration  as  a  result  of  catecholamine 
treatment,  even  without  basal  septal  hypertrophy. 
CASE REPORT
A  62-year-old  man  with  a  history  of  hypertension  was 
admitted  to  a  medical  center  due  to  stage  IIIA  non-small  cell 
lung  cancer.  The  cardiopulmonary  physical  examination,  which 
included  a  routine  transthoracic  echocardiographic  evaluation 
and a 12-lead electrocardiogram (ECG), did not reveal any signs 
of  heart  abnormalities.  Following  neoadjuvant  concurrent 
chemoradiation  treatment,  the  patient  underwent  left  lower 
lobectomy  and  mediastinal  lymphadencetomy.
Three  days  after  the  operation,  the  patient  developed  adult 
respiratory  distress  syndrome  with  shock  and  was  treated  with 
mechanical  ventilation,  intravenous  antibiotics,  volume  substitu-
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Figure 1. Chest  X-ray showed  diffuse  reticulonodular  opacities  in  both
lungs  and  pulmonary  edema.
Figure 2. Transthoracic echocardiogram. (A) Systolic anterior motion of the mitral leaflets with left ventricular outflow tract obstruction 
w a s  s h o w n .  ( B )  T h e  p e a k  p r e s s u r e  g r a d i e n t  m e a s u r e d  w i t h  c o n t i n u ous  Doppler  in  LVOT  was  73.3  mm  Hg.  (C)  Transthoracic 
echocardiography  with  color  Doppler  imaging  showed  flow  accelera t i o n  i n  L V O T .  ( D )  M o d e r a t e  a m o u n t  o f  m i t r a l  r e g u r g i t a t i o n  w a s  
revealed  on  color  Doppler  examination. 
examination  revealed  bilateral  crackle  in  the  basal  lung  and  a 
chest  x-ray  which  revealed  pulmonary  edema  (Figure  1).  These 
symptoms  improved  following  the  intravenous  infusion  of  the 
f u r o s e m i d e  a n d  d o b u t a m i n e .  
Over  the  course  of  the  next  three  weeks  of  treatment,  the 
patient experienced fever (up to 39℃) and recurrent hypotensive 
events,  which  were  treated  with  appropriate  antibiotics  and 
catecholamines.  The  patient's  vital  signs  included,  blood 
pressure  of  100/80  mm  Hg,  heart  rate  of  130  beats/min,  and   
central  venous  pressure  of  4  to  5  cm  Hg.  On  a  follow-up 
physical examination, a grade 3/6 systolic murmur was detected 
at  the  left  sternal  border.
The  transthoracic  echocardiogram  revealed  the  SAM  with 
LVOT  obstruction  (Figure  2A).  The  peak  pressure  gradient 
recorded with  continuous-wave Doppler in  LVOT was 73.3  mm 
Hg (Figure 2B). In addition, a color Doppler image detected flow 
acceleration  in  the  LVOT  and  moderate  amounts  of  mitral 
regurgitation  (Figure  2C,  2D).
Following  the  parenteral  substitution  of  crystalloid  and  colloid 
for  volume  replacement  as  well  as  phasing  out  the  catecho-
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Figure  3.  Transesophageal  echocardiography  was  done  to  evaluate  heart  function  after  the  treatment,  i.e.,  volume  replacement  and  stop  of 
catecholamine infusion and to rule out acute derangement from infective endocarditis. (A) There was no more systolic anterior motion of the mitral
v a l v e .  ( B )  T h e  a m o u n t  o f  m i t r a l  r e g u r g i t a t i o n  r e d u c e d  t o  t r i v i a l  degree.
lamine  treatment,  the  patient's  condition  improved  dramatically. 
We found the patient's cardiac murmur to have disappeared, the 
fever subsided, and the hemodynamic condition stabilized. Upon 
a  follow-up  evaluation,  a  transesophageal  echocardiogram 
revealed complete resolution of the SAM, LVOT obstruction, and 
mi t ral  regur gi t at i on ( Fi gure 3) . The pat i ent ' s m e c h a n i c a l  v e n t ilator 
was  successfully  removed  and  subsequently  transferred  to  the 
general  ward  without  any  further  or  residual  complications. 
DISCUSSION
It is well known that hypertrophic obstructive cardiomyopathy 
(HCM)  is  the  most  frequently  reported  cause  of  the  dynamic 
LVOT obstruction
1-3). As well, a hyperdynamic state as a result of 
catecholamine  therapy
6, 7) h a s  b e e n  l i n k e d  t o  t h i s  c o n d i t i o n .  
Dynamic LVOT obstruction has been reported in hypertensive 
patients  during  dobutamine  stress  echocardiography,  but  most 
of  these  cases  did  not  show  any  significant  clinical  or 
hemodynamic  changes
8-10).  A  few  cases  similar  to  our  case 
study  have  described  a  catecholamine-induced  dynamic  LVOT 
obstruction  compromised  by  hemodynamic  deterioration  in  a 
structurally  normal  heart
5, 11). 
Treatment  with  inotropic  agents  in  patients  experiencing 
shock  symptoms  remains  a  common  practice  and  mandatory 
mainstay  in  the  field  of  medicine.  However,  we  observed  that 
management  of  this  condition  with  catecholamine  may  result  in 
paradoxical  hemodynamic  deterioration.  The  mechanisms  behind 
the  catecholamine-induced  deterioration  may  include,  ischemic 
left  ventricular  dysfunction,  the  vasodilatation  effect  of  dobuta-
mine,  tachycardia  and  the  dynamic  LVOT  obstruction  resulting 
from  a  hypercontractile  state  in  relative  hypovolemia
9, 12, 13).
In our case study, hypovolemia in combination with a hyper-
dynamic state, induced by catecholamine administration was the 
key  mechanism  for  severe  dynamic  LVOT  obstruction  with 
haemodynamic deterioration. Cessation of catecholamine therapy 
and volume replacement completely reversed the dynamic LVOT 
obstruction,  SAM,  and  mitral  insufficiency.
We  determined  that  for  our  case  study,  hemodynamic 
deterioration  leading  to  dynamic  LVOT  obstruction  should  be 
considered  as  an  adverse  effect  of  catecholamine  treatment 
under the hypovolemia. A newly detected systolic murmur in the 
l e f t  l o w e r  s t e r n a l  b o r d e r  m a y  b e  n o t i c e d  u p o n  p h y s i c a l  
examination;  however  a  definitive  diagnosis  would  require  an 
echocardiographic examination. Early detection and correction of 
the  factors  leading  to  deterioration  of  the  heart,  which  include 
cessation  of  catecholamine  therapy  and  intravascular  volume 
replacement,  would  reverse  the  symptoms.
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